We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
2151
10x Genomics
TXG
$6.61B
$2.59K ﹤0.01%
69
+1
+1% +$44
DO
2152
DELISTED
Diamond Offshore Drilling, Inc.
DO
$2.58K ﹤0.01%
189
-658
-78% -$8.12K
VCYT icon
2153
Veracyte
VCYT
$3.8B
$2.57K ﹤0.01%
116
+12
+12% +$293
ESE icon
2154
ESCO Technologies
ESE
$7.92B
$2.57K ﹤0.01%
24
ZION icon
2155
Zions Bancorporation
ZION
$10.3B
$2.56K ﹤0.01%
59
+21
+55% +$866
VPG icon
2156
Vishay Precision Group
VPG
$914M
$2.54K ﹤0.01%
72
+30
+71% +$994
CEF icon
2157
Sprott Physical Gold and Silver Trust
CEF
$8.06B
$2.54K ﹤0.01%
125
BAND
2158
Bandwidth Inc
BAND
$1.61B
$2.54K ﹤0.01%
139
+104
+297% +$1.64K
WVE icon
2159
Wave Life Sciences
WVE
$1.2B
$2.54K ﹤0.01%
411
IMXI icon
2160
International Money Express
IMXI
$367M
$2.53K ﹤0.01%
111
HDSN
2161
Hudson Technologies
HDSN
$235M
$2.53K ﹤0.01%
230
FRO icon
2162
Frontline
FRO
$8.85B
$2.52K ﹤0.01%
108
SFBS
2163
ServisFirst Bancshares
SFBS
$4.86B
$2.52K ﹤0.01%
38
ASB icon
2164
Associated Banc-Corp
ASB
$5.91B
$2.47K ﹤0.01%
115
ANDE icon
2165
Andersons Inc
ANDE
$2.22B
$2.47K ﹤0.01%
43
CTEV
2166
Claritev Corp
CTEV
$556M
$2.46K ﹤0.01%
76
+35
+85% +$1.47K
ADT icon
2167
ADT
ADT
$5.58B
$2.46K ﹤0.01%
366
FLGT icon
2168
Fulgent Genetics
FLGT
$527M
$2.45K ﹤0.01%
113
+60
+113% +$1.49K
ADPT icon
2169
Adaptive Biotechnologies
ADPT
$3.97B
$2.45K ﹤0.01%
762
+229
+43% +$886
RXRX icon
2170
Recursion Pharmaceuticals
RXRX
$1.73B
$2.44K ﹤0.01%
245
CSAN icon
2171
Cosan
CSAN
$2.84B
$2.42K ﹤0.01%
+187
New +$2.69K
INBX
2172
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2.41K ﹤0.01%
69
URGN icon
2173
UroGen Pharma
URGN
$2.29B
$2.4K ﹤0.01%
160
+98
+158% +$1.6K
AEO icon
2174
American Eagle Outfitters
AEO
$3.01B
$2.4K ﹤0.01%
93
+9
+11% +$200
CBT icon
2175
Cabot Corp
CBT
$4.52B
$2.4K ﹤0.01%
26

Similar funds

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.